323990.KQ
Price:
$4400
Market Cap:
$101.97B
Established in 2010, Vaxcell-Bio Therapeutics Co., Ltd. specializes in the research, development, and commercialization of immune cell-based therapies designed to treat cancer, primarily operating within South Korea. The company's main base of operations is located in Hwasun-eup, South Korea.
Industry
Biotechnology
IPO Date
2020-09-22
Stock Exchange
KOE
Ticker
323990.KQ
According to Vaxcell-Bio Therapeutics Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -6.93. This represents a change of -46.78% compared to the average of -13.02 of the last 4 quarters.
The mean historical PE Ratio of Vaxcell-Bio Therapeutics Co., Ltd. over the last ten years is -45.23. The current -6.93 PE Ratio has changed 1.43% with respect to the historical average. Over the past ten years (40 quarters), 323990.KQ's PE Ratio was at its highest in in the June 2026 quarter at -7.32. The PE Ratio was at its lowest in in the December 2022 quarter at -101.54.
Average
-45.23
Median
-31.03
Minimum
-114.81
Maximum
-0.00
Discovering the peaks and valleys of Vaxcell-Bio Therapeutics Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 481.77%
Maximum Annual PE Ratio = -0.00
Minimum Annual Increase = -100.00%
Minimum Annual PE Ratio = -114.81
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -17.30 | -23.20% |
| 2024 | -22.53 | -51.92% |
| 2023 | -46.85 | -44.26% |
| 2022 | -84.06 | -26.79% |
| 2021 | -114.81 | 481.77% |
| 2020 | -0.00 | -100.00% |
The current PE Ratio of Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-28.89
5-year avg
-57.11
10-year avg
-45.23
Vaxcell-Bio Therapeutics Co., Ltd.’s PE Ratio is less than Hana Technology Co., Ltd. (57.08), less than TOP MATERIAL Co., Ltd (-2.30), less than LOT VACUUM Co., Ltd. (152.69), greater than JEIO Co., Ltd. (-96.75), greater than T-Robotics.Co.,Ltd. (-10.86), less than LabGenomics Co., Ltd. (-0.83), less than DRTECH Corporation (-5.45), less than Gc Cell Corp. (-0.98), less than Dongkuk Structures & Construction Company Limited (-5.05), less than APS Innovation Co., Ltd. (6.59),
| Company | PE Ratio | Market cap |
|---|---|---|
| 57.08 | $126.24B | |
| -2.30 | $82.58B | |
| 152.69 | $202.98B | |
| -96.75 | $159.54B | |
| -10.86 | $335.21B | |
| -0.83 | $42.76B | |
| -5.45 | $64.86B | |
| -0.98 | $228.41B | |
| -5.05 | $89.90B | |
| 6.59 | $79.01B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaxcell-Bio Therapeutics Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vaxcell-Bio Therapeutics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Vaxcell-Bio Therapeutics Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ)?
What is the highest PE Ratio for Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ)?
What is the 3-year average PE Ratio for Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ)?
What is the 5-year average PE Ratio for Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ)?
How does the current PE Ratio for Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ) compare to its historical average?